Value proposition

The first minimally invasive treatment tailored for tricuspid valve.

Approxima is an early stage MedTech startup based in Milan, Italy. Our mission is to develop a percutaneous tricuspid valve repair system based on a right ventricular reshaping approach to treat patients with tricuspid regurgitation.
The company is conducting preclinical feasibility phase studies to demonstrate in-vivo feasibility, efficacy, and safety.